Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zoll Shifts Focus From Defib To Perfusion For Cardiac Emergency Market

This article was originally published in The Gray Sheet

Executive Summary

Forthcoming American Heart Association guidelines on emergency cardiac resuscitation will spur demand for Revivant's AutoPulse, according to Zoll Medical
Advertisement

Related Content

Deca-Medics Plans CPR-Assist Device 510(k) Submission By Summer 2011
Deca-Medics Plans CPR-Assist Device 510(k) Submission By Summer 2011
Zoll Takes Aim At Hospital Defibrillator Market In 2007; Stock Up 131% In ’06
Zoll Takes Aim At Hospital Defibrillator Market In 2007; Stock Up 131% In ’06
Zoll AutoPulse CPR Assist: Two Studies Present Conflicting Data
Zoll AutoPulse CPR Assist: Two Studies Present Conflicting Data
Thomas Weisel Partners Healthcare Tailwinds Conference In Brief
NIH-Led Consortium Will Help FDA Design Cardiac Resuscitation Trials
Zoll Seeks To Move Blood, AED Market With New CPR Device
Zoll Seeks To Move Blood, AED Market With New CPR Device
Advertisement
UsernamePublicRestriction

Register

MT019992

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel